News from durect corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 29, 2016, 12:15 ET DURECT Announces Closing of Public Offering of Common Stock

DURECT Corporation (Nasdaq: DRRX) today announced the closing of an underwritten public offering of 13,800,000 shares of its common stock, offered...


Apr 28, 2016, 16:30 ET DURECT Corporation Invites You to Join its First Quarter 2016 Earnings Conference Call

 In conjunction with DURECT Corporation's (Nasdaq: DRRX) first quarter 2016 financial results press release, you are invited to listen to the...


Apr 26, 2016, 09:00 ET DURECT Announces Pricing of Public Offering of Common Stock

DURECT Corporation (Nasdaq: DRRX) today announced the pricing of an underwritten public offering of 12,000,000 shares of its common stock, offered...


Apr 25, 2016, 16:01 ET DURECT Announces Proposed Public Offering of Common Stock

 DURECT Corporation (Nasdaq: DRRX) today announced that it is offering, subject to market conditions, shares of its common stock in an...


Apr 12, 2016, 18:34 ET DURECT Announces FDA Acceptance of REMOXY® NDA, PDUFA Date of September 25, 2016

 DURECT Corporation (Nasdaq: DRRX) today announced its licensee, Pain Therapeutics (Nasdaq: PTIE), has been informed by the U.S. Food and Drug...


Apr 07, 2016, 17:00 ET DURECT Announces POSIMIR® Program Update

DURECT Corporation (Nasdaq: DRRX) today announced that after the PERSIST Phase 3 trial for POSIMIR® was underway and enrolling patients at...


Mar 29, 2016, 11:15 ET DURECT Announces Resubmission of REMOXY® New Drug Application to the U.S. Food and Drug Administration

DURECT Corporation (Nasdaq: DRRX) today announced its licensee, Pain Therapeutics (Nasdaq: PTIE), has resubmitted the New Drug Application (NDA)...


Feb 29, 2016, 16:05 ET DURECT Corporation Announces Fourth Quarter 2015 Financial Results and Update of Programs

DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended December 31, 2015. Total revenues were $5.2 million...


Feb 18, 2016, 16:30 ET DURECT Corporation Invites You to Join its Fourth Quarter 2015 Earnings Conference Call

 In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2015 financial results press release, you are invited to listen to the...


Jan 28, 2016, 17:00 ET DURECT to Present at the BIO CEO & Investor Conference

 DURECT Corporation (Nasdaq: DRRX) announced today that Matt Hogan (Chief Financial Officer) will be presenting at the BIO CEO & Investor...


Jan 11, 2016, 08:00 ET DURECT Announces Initiation of DUR-928 Dosing in Patients

DURECT Corporation (Nasdaq: DRRX) today announced it has initiated a single-ascending-dose Phase 1b clinical trial with DUR-928 in patients with...


Jan 06, 2016, 08:00 ET DURECT Announces Positive Phase 1 Data for DUR-928

 DURECT Corporation (Nasdaq: DRRX) today announced the successful completion of a Phase 1 clinical trial with an injectable formulation of...


Nov 30, 2015, 16:15 ET DURECT to Present at the Oppenheimer Healthcare Conference

 DURECT Corporation (Nasdaq: DRRX) announced today that Matt Hogan, Chief Financial Officer, will be presenting at the Oppenheimer Healthcare...


Nov 05, 2015, 16:30 ET DURECT to Present at the Stifel Nicolaus Healthcare Conference

DURECT Corporation (Nasdaq: DRRX) announced today that Jim Brown, President and Chief Executive Officer, will be presenting at the Stifel Nicolaus...


Nov 02, 2015, 16:05 ET DURECT Corporation Announces Third Quarter 2015 Financial Results and Update of Programs

DURECT Corporation (Nasdaq: DRRX) announced today financial results for the third quarter of 2015.  Total revenues were $4.7 million and net...


Oct 26, 2015, 16:30 ET DURECT Corporation Invites You to Join its Third Quarter 2015 Earnings Conference Call

In conjunction with DURECT Corporation's (Nasdaq: DRRX) third quarter 2015 financial results press release, you are invited to listen to the...


Oct 15, 2015, 16:15 ET DURECT to Present at the BIO Investor Forum

 DURECT Corporation (Nasdaq: DRRX) announced today that Matt Hogan, Chief Financial Officer, will be presenting at the BIO Investor Forum...


Aug 27, 2015, 16:15 ET DURECT to Participate in Upcoming Healthcare Conferences

DURECT Corporation (Nasdaq: DRRX) announced today that management is scheduled to present at three upcoming healthcare conferences.  -...


Aug 03, 2015, 16:05 ET DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs

 DURECT Corporation (Nasdaq: DRRX) announced today financial results for the second quarter of 2015.  Total revenues were $4.4 million and...


Jul 24, 2015, 16:30 ET DURECT Corporation Invites You to Join its Second Quarter 2015 Earnings Conference Call

In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2015 financial results press release, you are invited to listen to the...


Jun 29, 2015, 16:30 ET DURECT to Present at the Cantor Fitzgerald Healthcare Conference

DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown, President and CEO, will be presenting at the Cantor Fitzgerald Healthcare...


Jun 23, 2015, 08:00 ET DURECT Announces Plans for a New POSIDUR™ (SABER®-Bupivacaine) Clinical Trial

 DURECT Corporation (Nasdaq: DRRX) announced that, based on feedback from the FDA, it plans to conduct a new POSIDUR™...


May 18, 2015, 08:30 ET DURECT Announces Positive Results from DUR-928 Multi-Dose Phase 1 Study

DURECT Corporation (Nasdaq: DRRX) today announced that it has obtained positive results from a multi-dose Phase 1 clinical trial with an oral...


Apr 30, 2015, 19:36 ET DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs

 DURECT Corporation (Nasdaq: DRRX) announced today financial results for the first quarter of 2015.  Total revenues were $4.8 million and...


Apr 22, 2015, 16:30 ET DURECT Corporation Invites You to Join its First Quarter 2015 Earnings Conference Call

In conjunction with DURECT Corporation's (Nasdaq: DRRX) first quarter 2015 financial results press release, you are invited to listen to the...